USFDA conducts inspection at Alembic Pharma’s Panelav facility

16 Mar 2020 Evaluate

US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceutical’s General Oral Solid Formulation Facility located at Panelav from March 9, 2020 to March 13, 2020. This was a scheduled inspection and at the end of the inspection, the USFDA issued a Form 483 with four procedural observations. None of the observations are related to data integrity or repetitive in nature.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

962.55 10.55 (1.11%)
23-May-2024 12:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1491.00
Dr. Reddys Lab 5898.60
Cipla 1498.95
Zydus Lifesciences 1086.00
Lupin 1636.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.